New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Neoantigen discovery sheds light on cancer immunogenicity

Neoantigen discovery sheds light on cancer immunogenicity

In a recent article published inNature Communications,researchers reported a proteogenomic approach to investigate fresh solid melanoma tumor material. The approach combines liquid chromat
World medicine November 15,2023
Neoantigen discovery sheds light on cancer immunogenicity

Neoantigen discovery sheds light on cancer immunogenicity

In a recent article published inNature Communications,researchers reported a proteogenomic approach to investigate fresh solid melanoma tumor material. The approach combines liquid chromat
World medicine November 15,2023
Study explores the diverse expression patterns of T cell priming markers across cancers

Study explores the diverse expression patterns of T cell priming markers across cancers

A recent study published innpj Genomic Medicineexplored transcriptomics of T-cell priming markers (TPMs) across different cancers.Study:T-cell priming transcriptomic markers: implica
World medicine November 15,2023
Study explores the diverse expression patterns of T cell priming markers across cancers

Study explores the diverse expression patterns of T cell priming markers across cancers

A recent study published innpj Genomic Medicineexplored transcriptomics of T-cell priming markers (TPMs) across different cancers.Study:T-cell priming transcriptomic markers: implica
World medicine November 15,2023
The safety of mesenchymal stem cell therapy for treating severe COVID-19

The safety of mesenchymal stem cell therapy for treating severe COVID-19

In a recent study published inScientific Reports,researchers discuss the results of a multicentric, randomized, placebo-controlled trial to determine the safety andefficacy ofn
World medicine November 15,2023
The safety of mesenchymal stem cell therapy for treating severe COVID-19

The safety of mesenchymal stem cell therapy for treating severe COVID-19

In a recent study published inScientific Reports,researchers discuss the results of a multicentric, randomized, placebo-controlled trial to determine the safety andefficacy ofn
World medicine November 15,2023
New trial to assess sentinel lymph node removal during surgery for early-stage endometrial cancer

New trial to assess sentinel lymph node removal during surgery for early-stage endometrial cancer

University of Queensland researchers have received a $3.1 million grant for a trial which could revolutionize endometrial cancer treatment.Research DirectorProfessor Andreas Obermair at UQ's
World medicine November 15,2023
New trial to assess sentinel lymph node removal during surgery for early-stage endometrial cancer

New trial to assess sentinel lymph node removal during surgery for early-stage endometrial cancer

University of Queensland researchers have received a $3.1 million grant for a trial which could revolutionize endometrial cancer treatment.Research DirectorProfessor Andreas Obermair at UQ's
World medicine November 15,2023
Computational model can help identify the sites of origin for enigmatic cancers

Computational model can help identify the sites of origin for enigmatic cancers

For a small percentage of cancer patients, doctors are unable to determine where their cancer originated. This makes it much more difficult to choose a treatment for those patients, because many cance
World medicine November 15,2023
Computational model can help identify the sites of origin for enigmatic cancers

Computational model can help identify the sites of origin for enigmatic cancers

For a small percentage of cancer patients, doctors are unable to determine where their cancer originated. This makes it much more difficult to choose a treatment for those patients, because many cance
World medicine November 15,2023
AI-based predictive tool could help guide treatment of cancer

AI-based predictive tool could help guide treatment of cancer

Researchers at Dana-Farber Cancer Institute have created an AI-based tool that uses tumor gene sequencing data to predict the primary source of a patient's cancer. The study, published in in
World medicine November 15,2023
AI-based predictive tool could help guide treatment of cancer

AI-based predictive tool could help guide treatment of cancer

Researchers at Dana-Farber Cancer Institute have created an AI-based tool that uses tumor gene sequencing data to predict the primary source of a patient's cancer. The study, published in in
World medicine November 15,2023
Molecular insights: Detecting gene fusions offers new avenues for advanced cancer management

Molecular insights: Detecting gene fusions offers new avenues for advanced cancer management

In a recent article published intheBiologicsJournal, researchers examined de-identified clinical data to identify gene fusions by next-generation deoxy- and ribonucleic acids (DNA an
World medicine November 15,2023
Molecular insights: Detecting gene fusions offers new avenues for advanced cancer management

Molecular insights: Detecting gene fusions offers new avenues for advanced cancer management

In a recent article published intheBiologicsJournal, researchers examined de-identified clinical data to identify gene fusions by next-generation deoxy- and ribonucleic acids (DNA an
World medicine November 15,2023
New AI platform could allow dentists to read radiograms with higher accuracy

New AI platform could allow dentists to read radiograms with higher accuracy

An artificial intelligence (AI) platform could allow dentists and dental students to read radiograms (X-rays) with higher accuracy, helping them to better detect tooth decay and gum diseases.The platf
World medicine November 15,2023
New AI platform could allow dentists to read radiograms with higher accuracy

New AI platform could allow dentists to read radiograms with higher accuracy

An artificial intelligence (AI) platform could allow dentists and dental students to read radiograms (X-rays) with higher accuracy, helping them to better detect tooth decay and gum diseases.The platf
World medicine November 15,2023
Effect of mutations in cancer-driving genes across human cancers

Effect of mutations in cancer-driving genes across human cancers

In a recent study published inScientific Reports,researchers used multiple publically available cancer sequencing project datasets encompassing 20,331 primary tumor genomic sequences repre
World medicine November 15,2023
Effect of mutations in cancer-driving genes across human cancers

Effect of mutations in cancer-driving genes across human cancers

In a recent study published inScientific Reports,researchers used multiple publically available cancer sequencing project datasets encompassing 20,331 primary tumor genomic sequences repre
World medicine November 15,2023
Are inflammatory bowel disease patients more at risk of colorectal cancer?

Are inflammatory bowel disease patients more at risk of colorectal cancer?

In a recent study published in the journalFrontiers in Medicine, researchers analyzed data from a large cohort of inflammatory bowel disease (IBD) patients and compared the risk and frequency of
World medicine November 15,2023
Are inflammatory bowel disease patients more at risk of colorectal cancer?

Are inflammatory bowel disease patients more at risk of colorectal cancer?

In a recent study published in the journalFrontiers in Medicine, researchers analyzed data from a large cohort of inflammatory bowel disease (IBD) patients and compared the risk and frequency of
World medicine November 15,2023
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com